4/A: Inari Medical Director Catherine Szyman Amends Form 4 Filing to Include Power of Attorney

Catherine Szyman, a director at Inari Medical, amended her Form 4 filing to include a Power of Attorney, related to restricted stock units granted on April 24, 2024.

Summary

• Catherine Szyman, a director of Inari Medical, Inc., filed an amended Form 4 with the SEC.
• The amendment, filed on May 31, 2024, updates the original Form 4 filed on April 26, 2024.
• The purpose of the amendment is to include a Power of Attorney granted to an attorney-in-fact.
• The original transaction reported was the acquisition of 4,126 shares of Common Stock at a price of $42.41 on April 24, 2024.
• These shares represent restricted stock units that vest in full on the earlier of the day prior to the Issuer's next annual meeting of stockholders or one year from the date of grant.
• Following the reported transaction, Szyman beneficially owns 22,429 shares of Common Stock.
• The Power of Attorney, executed on July 26, 2023, authorizes specific individuals to act on Szyman's behalf regarding SEC filings related to Inari Medical securities.

Sentiment

Score: 7

Explanation: The document is a standard regulatory filing related to insider transactions and administrative updates, indicating a neutral sentiment.

Industry Context

This filing is a routine disclosure related to insider transactions and is required by the SEC to ensure transparency in the market.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.

Key Dates